LYN-1604 2HCl 2216753-86-3 (HCl)
LYN-1604 is a novel ULK1 activator.It inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis. LYN-1604, to be the best candidate for a ULK1 agonist. LYN-1604 induced cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis. LYN-1604 has potential for good therapeutic effects on TNBC by targeting ULK1-modulated cell death in vivo.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
657.54
Molecular Formula
C33H45Cl4N3O2
Notes
Research use only, not for human use.
Receptor
ULK1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1080581-01 0.02 mg (E-Coli)
Recombinant Pseudotsuga menziesii Nucleoside diphosphate kinase 1
Ask
View Details MBS1080581-02 0.1 mg (E-Coli)
Recombinant Pseudotsuga menziesii Nucleoside diphosphate kinase 1
Ask
View Details MBS1080581-03 0.02 mg (Yeast)
Recombinant Pseudotsuga menziesii Nucleoside diphosphate kinase 1
Ask
View Details 
MBS1080581-04 0.1 mg (Yeast)
Recombinant Pseudotsuga menziesii Nucleoside diphosphate kinase 1
Ask
View Details 
MBS1080581-05 0.02 mg (Baculovirus)
Recombinant Pseudotsuga menziesii Nucleoside diphosphate kinase 1
Ask
View Details MBS1080581-06 1 mg (E-Coli)
Recombinant Pseudotsuga menziesii Nucleoside diphosphate kinase 1
Ask
View Details